1.
Ortiz LD, Syro LV, Scheithauer BW, Rotondo F, Uribe H, Fadul CE, et al. Temozolomide in aggressive pituitary adenomas and carcinomas. Clinics [Internet]. 2012 Jan. 1 [cited 2024 Jul. 21];67(supl.1):119-23. Available from: https://revistas.usp.br/clinics/article/view/19731